Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
American Journal of Translational Research|January 17, 2022
Illustrative and historic cases of phenoconversionVeronique Michaud, Pamela Dow, Jacques TurgeonClinical Therapeutics|January 22, 2023
Multidrug Interactions: Why Do They Occur and How to Handle?Pamela Dow, Veronique Michaud, Jacques TurgeonThe American Journal of Managed Care|June 23, 2022
Revisiting conclusions on the empiric segmentation of high-risk patientsVeronique Michaud, Pamela Dow, Jacques TurgeonPharmaceutics|February 5, 2021
Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and PolypharmacyVeronique Michaud, Jacques TurgeonDrug Metabolism Letters|May 8, 2010
Assessment of competitive and mechanism-based inhibition by clarithromycin: use of domperidone as a CYP3A probe-drug substrate and various enzymatic sources including a new cell-based assay with freshly isolated human hepatocytesVeronique Michaud, Jacques TurgeonJournal of Clinical Pharmacology|August 12, 2021
Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive InhibitionTao Long, Rodrigo Cristofoletti, Brian Cicali, et al.Journal of Clinical Medicine|July 9, 2020
ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS SystemVeronique Michaud, Malavika Deodhar, Meghan Arwood, et al.International Journal of Molecular Sciences|April 30, 2021
Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier LevelSweilem B Al Rihani, Lucy I Darakjian, Malavika Deodhar, et al.Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large PopulationsSebastian Härtter, Veronique Michaud, Matt K Smith, et al.Clinical and Translational Science|September 5, 2020
Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed DrugsVeronique Michaud, Pamela Dow, Sweilem B Al Rihani, et al.Pageof 12